Trial Profile
A real world study evaluating the risk of non-vertebral fracture in japanese women with osteoporosis treated with raloxifene compared with alendronate
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 10 Apr 2018
Price :
$35
*
At a glance
- Drugs Raloxifene (Primary) ; Alendronic acid
- Indications Fracture; Osteoporosis
- Focus Therapeutic Use
- Sponsors Eli Lilly Japan
- 10 Apr 2018 New trial record